Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: FinnországFázis nélkül

FINtick - a Prospective Multicenter Study on Tick-borne Infections in Finland

A legfontosabb adatok

Ki végzi
Turku University Hospital
Hol
Helsinki, Mariehamn és Turku (Finnország)Mind a 3 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
850 fő, tervezett
Kezdés
2025. ápr. 23.
Várható befejezés
2034. dec. 31.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A regiszteradat frissítve
2026. október 27.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for children and adults who are being checked because a doctor suspects a tick-borne disease. Participants are followed for six months with questionnaires and samples.

Életkor
1 year and older
Nem
All sexes can join
A betegség stádiuma
A doctor suspects a disease spread by ticks, such as Lyme borreliosis or tick-borne encephalitis (TBE).

A részvétel fő kizáró okai

  • Prisoners
  • Adults who cannot make their own decision, unless next of kin gives consent
  • People who cannot attend the first follow-up visit or phone call
  • People not willing to give a blood sample at the start

A regiszter feltételei, szó szerint

Mind a 5 feltétel megnézéseKevesebb

Ki vehet részt

  • Clinical suspicion of tick-borne disease

Ki nem vehet részt

  • Prisoners
  • Adults who are unable to decide, unless next of kin gives consent
  • Patients, who cannot attend the first follow-up visit or phone call
  • Patients, who are not willing to give a blood sample at the initiation

Helyszínek itt: Finnország

  • Helsinki University Central HospitalHelsinki, FinnországContact: Elisa Kortela, MD, PhDRésztvevőt keres
  • Ålands hälso- och sjukcård ÅHSMariehamn, FinnországContact: Marika Nordberg, MD, PhDToborzás még nem indult
  • Turku University HospitalTurku, FinnországContact: Ulla Hohenthal, MD, PhDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Ticks in Finland can carry several microbes that may infect humans. The best known tick-borne diseases are Lyme borreliosis and tick-borne encephalitis (TBE). In recent years, scientists have also found other microbes in Finnish ticks, such as Anaplasma, Rickettsia, Neoehrlichia, Borrelia miyamotoi, and Babesia. Infections caused by these microbes are called emerging tick-borne diseases. Climate change may also increase the number of ticks and expand their range further north. This could lead to more tick-borne diseases in the future.

A teljes eredeti leírásKevesebb

The public health impact of these emerging infections is still unclear. Some of them may cause severe illness, especially in people with weakened immune systems or without a spleen. However, we still know little about how common these infections are, how they develop in the body, and what symptoms they cause. Some people may have no symptoms, while others may become seriously ill. Good diagnostic tests are also lacking.

More knowledge is also needed about Lyme borreliosis and TBE. Some forms of Lyme disease, such as arthritis, heart inflammation, or eye problems, may be underdiagnosed. In addition, TBE cases have increased in Finland in recent years. This study will examine the symptoms, recovery, and quality of life of patients with these infections.

Another goal is to improve laboratory diagnostics. Current tests for Lyme disease and TBE mainly detect antibodies. These tests cannot always tell when the infection occurred or distinguish a past Lyme borreliosis infection from a current one. This also makes it difficult to detect reinfections in Lyme borreliosis or TBE-infections in vaccinated individuals. By collecting samples from patients, we aim to develop better diagnostic methods.

The main goal of the study is to improve knowledge about tick-borne diseases in Finland. We will study how common emerging infections are, what symptoms they cause, and whether people can have more than one tick-borne infection at the same time. We will also examine how the immune system responds to these infections and how this relates to disease severity and recovery.

This study includes both children and adults who are being examined for a suspected tick-borne disease. Participants will be followed for six months using questionnaires at initiation, one, three, and six months. Blood samples and other samples, depending on the patient's symptoms, will be collected together with routine clinical samples. The samples will be analyzed to detect tick-borne pathogens and antibodies against them. Molecular tests (PCR) will look for the genetic material of the microbes. Researchers will also search for new biological markers of these diseases and study the immune response using advanced laboratory methods.

The study will be conducted in collaboration with the SWETICK study.

A vizsgálat 3 csoportja

  • TBD

    Patients with confirmed tick-borne disease

  • Possible TBD

    Patients with possible but not confirmed tick-borne disease

  • Non-TBD

    Patients investigated for suspected tick-borne disease but diagnosed with another condition (tick-borne disease excluded)

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. október 27.